메뉴 건너뛰기




Volumn 27, Issue 2, 2013, Pages 175-179

Lipid profiles in untreated patients with dermatomyositis

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; CORTICOSTEROID; DISEASE MODIFYING ANTIRHEUMATIC DRUG; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

EID: 84872682005     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2011.04437.x     Document Type: Article
Times cited : (23)

References (33)
  • 1
    • 0141651951 scopus 로고    scopus 로고
    • Polymyositis and dermatomyositis
    • Dalakas MC, Hohlfeld R,. Polymyositis and dermatomyositis. Lancet 2003; 362: 971-982.
    • (2003) Lancet , vol.362 , pp. 971-982
    • Dalakas, M.C.1    Hohlfeld, R.2
  • 2
    • 0036108902 scopus 로고    scopus 로고
    • Outcome in patients with idiopathic inflammatory myositis: Morbidity and mortality
    • Sultan SM, Ioannou Y, Moss K, Isenberg DA,. Outcome in patients with idiopathic inflammatory myositis: morbidity and mortality. Rheumatology 2002; 41: 22-26.
    • (2002) Rheumatology , vol.41 , pp. 22-26
    • Sultan, S.M.1    Ioannou, Y.2    Moss, K.3    Isenberg, D.A.4
  • 3
    • 1642494599 scopus 로고    scopus 로고
    • Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features: A longitudinal study of 162 cases
    • Danko K, Ponyi A, Constantin T, Borgulya G, Szegedi G,. Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features: a longitudinal study of 162 cases. Medicine 2004; 83: 35-42.
    • (2004) Medicine , vol.83 , pp. 35-42
    • Danko, K.1    Ponyi, A.2    Constantin, T.3    Borgulya, G.4    Szegedi, G.5
  • 4
    • 0017640201 scopus 로고
    • Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis
    • Bohan A, Peter JB, Bowman RL, Bowman RL, Pearson CM,. Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine 1977; 56: 255-286.
    • (1977) Medicine , vol.56 , pp. 255-286
    • Bohan, A.1    Peter, J.B.2    Bowman, R.L.3    Bowman, R.L.4    Pearson, C.M.5
  • 5
    • 37749038565 scopus 로고    scopus 로고
    • Systemic lupus erythematosus and "lupus dyslipoproteinemia"
    • de Carvalho JF, Bonfá E, Borba EF,. Systemic lupus erythematosus and "lupus dyslipoproteinemia". Autoimmun Rev 2008; 7: 246-250.
    • (2008) Autoimmun Rev , vol.7 , pp. 246-250
    • De Carvalho, J.F.1    Bonfá, E.2    Borba, E.F.3
  • 6
    • 62849084638 scopus 로고    scopus 로고
    • Lipid profiles in patients with rheumatoid arthritis: Mechanisms and the impact of treatment
    • Steiner G, Urowitz MB,. Lipid profiles in patients with rheumatoid arthritis: mechanisms and the impact of treatment. Semin Arthritis Rheum 2009; 38: 372-381.
    • (2009) Semin Arthritis Rheum , vol.38 , pp. 372-381
    • Steiner, G.1    Urowitz, M.B.2
  • 8
    • 33845680179 scopus 로고    scopus 로고
    • Mechanisms of dyslipoproteinemias in systemic lupus erythematosus
    • Borba EF, Carvalho JF, Bonfá E,. Mechanisms of dyslipoproteinemias in systemic lupus erythematosus. Clin Dev Immunol 2006; 13: 203-208.
    • (2006) Clin Dev Immunol , vol.13 , pp. 203-208
    • Borba, E.F.1    Carvalho, J.F.2    Bonfá, E.3
  • 9
    • 70449688271 scopus 로고    scopus 로고
    • Effects of inflammation on cholesterol metabolism: Impact on systemic lupus erythematosus
    • Reiss AB,. Effects of inflammation on cholesterol metabolism: impact on systemic lupus erythematosus. Curr Rheumatol Rep 2009; 11: 255-260.
    • (2009) Curr Rheumatol Rep , vol.11 , pp. 255-260
    • Reiss, A.B.1
  • 10
    • 33751291002 scopus 로고    scopus 로고
    • Patterns of cardiovascular risk in rheumatoid arthritis
    • Solomon DH, Goodson NJ, Katz JN, et al. Patterns of cardiovascular risk in rheumatoid arthritis. Ann Rheum Dis 2006; 65: 1608-1612.
    • (2006) Ann Rheum Dis , vol.65 , pp. 1608-1612
    • Solomon, D.H.1    Goodson, N.J.2    Katz, J.N.3
  • 12
    • 0016850495 scopus 로고
    • Polymyositis and dermatomyositis
    • Bohan A, Peter JB,. Polymyositis and dermatomyositis. N Engl J Med 1975; 292: 344-347.
    • (1975) N Engl J Med , vol.292 , pp. 344-347
    • Bohan, A.1    Peter, J.B.2
  • 13
    • 32644437182 scopus 로고    scopus 로고
    • Mechanisms of disease: Atherosclerosis in autoimmune diseases
    • Sherer Y, Shoenfeld Y,. Mechanisms of disease: atherosclerosis in autoimmune diseases. Nat Clin Pract Rheumatol 2006; 2: 99-106.
    • (2006) Nat Clin Pract Rheumatol , vol.2 , pp. 99-106
    • Sherer, Y.1    Shoenfeld, Y.2
  • 14
    • 24144438580 scopus 로고    scopus 로고
    • Atherosclerosis in patients with autoimmune disorders
    • Frostegård J,. Atherosclerosis in patients with autoimmune disorders. Arterioscler Thromb Vasc Biol 2005; 25: 1776-1785.
    • (2005) Arterioscler Thromb Vasc Biol , vol.25 , pp. 1776-1785
    • Frostegård, J.1
  • 15
    • 80054752325 scopus 로고    scopus 로고
    • Clinical status and cardiovascular risk profile of adults with a history of juvenile dermatomyositis
    • Eimer MJ, Brickman WJ, Seshadri R, et al. Clinical status and cardiovascular risk profile of adults with a history of juvenile dermatomyositis. J Pediatr 2011; 159: 795-801.
    • (2011) J Pediatr , vol.159 , pp. 795-801
    • Eimer, M.J.1    Brickman, W.J.2    Seshadri, R.3
  • 16
    • 34247550873 scopus 로고    scopus 로고
    • Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: Effect of early treatment-a prospective, controlled study
    • Georgiadis AN, Papavasiliou EC, Lourida ES, et al. Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment-a prospective, controlled study. Arthritis Res Ther 2006; 8: R82.
    • (2006) Arthritis Res Ther , vol.8
    • Georgiadis, A.N.1    Papavasiliou, E.C.2    Lourida, E.S.3
  • 17
    • 28844454106 scopus 로고    scopus 로고
    • Lipid profiles among US elderly with untreated rheumatoid arthritis - The Third National Health and Nutrition Examination Survey
    • Choi HK, Seeger JD,. Lipid profiles among US elderly with untreated rheumatoid arthritis-the Third National Health and Nutrition Examination Survey. J Rheumatol 2005; 32: 2311-2316.
    • (2005) J Rheumatol , vol.32 , pp. 2311-2316
    • Choi, H.K.1    Seeger, J.D.2
  • 18
    • 0008856783 scopus 로고    scopus 로고
    • Lipid profiles in untreated patients with rheumatoid arthritis
    • Park YB, Lee SK, Lee WK, et al. Lipid profiles in untreated patients with rheumatoid arthritis. J Rheumatol 1999; 26: 1701-1704.
    • (1999) J Rheumatol , vol.26 , pp. 1701-1704
    • Park, Y.B.1    Lee, S.K.2    Lee, W.K.3
  • 19
    • 20044362604 scopus 로고    scopus 로고
    • Lp(a) lipoprotein and lipids in patients with rheumatoid arthritis: Serum levels and relationship to inflammation
    • Dursunoglu D, Evrengul H, Polat B, et al. Lp(a) lipoprotein and lipids in patients with rheumatoid arthritis: serum levels and relationship to inflammation. Rheumatol Int 2005; 25: 241-245.
    • (2005) Rheumatol Int , vol.25 , pp. 241-245
    • Dursunoglu, D.1    Evrengul, H.2    Polat, B.3
  • 20
    • 0025239836 scopus 로고
    • Antiphospholipid antibodies: Anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders; Prevalence and clinical significance
    • Love PE, Santoro SA,. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders; prevalence and clinical significance. Ann Intern Med 1990; 112: 682-698.
    • (1990) Ann Intern Med , vol.112 , pp. 682-698
    • Love, P.E.1    Santoro, S.A.2
  • 21
    • 17144377882 scopus 로고    scopus 로고
    • Anti-lipoprotein lipase antibody in systemic sclerosis: Association with elevated serum triglyceride concentrations
    • Kodera M, Hayakawa I, Komura K, et al. Anti-lipoprotein lipase antibody in systemic sclerosis: association with elevated serum triglyceride concentrations. J Rheumatol 2005; 32: 629-636.
    • (2005) J Rheumatol , vol.32 , pp. 629-636
    • Kodera, M.1    Hayakawa, I.2    Komura, K.3
  • 22
    • 0041569770 scopus 로고    scopus 로고
    • Cross-reactivity between anti-cardiolipin, anti-high-density lipoprotein and anti-apolipoprotein A-I IgG antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome
    • Delgado AJ, Kumar S, Isenberg DA,. Cross-reactivity between anti-cardiolipin, anti-high-density lipoprotein and anti-apolipoprotein A-I IgG antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome. Rheumatology 2003; 42: 893-899.
    • (2003) Rheumatology , vol.42 , pp. 893-899
    • Delgado, A.J.1    Kumar, S.2    Isenberg, D.A.3
  • 24
    • 0030758970 scopus 로고    scopus 로고
    • Dyslipoproteinemias in systemic lupus erythematosus: Influence of disease, activity, and anticardiolipin antibodies
    • Borba EF, Bonfa E,. Dyslipoproteinemias in systemic lupus erythematosus: influence of disease, activity, and anticardiolipin antibodies. Lupus 1997; 6: 533-539.
    • (1997) Lupus , vol.6 , pp. 533-539
    • Borba, E.F.1    Bonfa, E.2
  • 25
    • 0023684531 scopus 로고
    • A phase i trial of intravenously administered recombinant tumor necrosis factor-alpha in cancer patients
    • Feinberg B, Kurzrock R, Talpaz M, Blick M, Saks S, Gutterman JU,. A phase I trial of intravenously administered recombinant tumor necrosis factor-alpha in cancer patients. J Clin Oncol 1988; 6: 1328-1334.
    • (1988) J Clin Oncol , vol.6 , pp. 1328-1334
    • Feinberg, B.1    Kurzrock, R.2    Talpaz, M.3    Blick, M.4    Saks, S.5    Gutterman, J.U.6
  • 26
    • 0141676423 scopus 로고    scopus 로고
    • Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor alpha/tumor necrosis factor receptor system in systemic lupus erythematosus
    • Svenungsson E, Gunnarsson I, Fei GZ, Lundberg IE, Klareskog L, Frostegård J,. Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor alpha/tumor necrosis factor receptor system in systemic lupus erythematosus. Arthritis Rheum 2003; 48: 2533-2540.
    • (2003) Arthritis Rheum , vol.48 , pp. 2533-2540
    • Svenungsson, E.1    Gunnarsson, I.2    Fei, G.Z.3    Lundberg, I.E.4    Klareskog, L.5    Frostegård, J.6
  • 27
    • 13244252637 scopus 로고    scopus 로고
    • Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis
    • Popa C, Netea MG, Radstake T, et al. Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis. Ann Rheum Dis 2005; 64: 303-305.
    • (2005) Ann Rheum Dis , vol.64 , pp. 303-305
    • Popa, C.1    Netea, M.G.2    Radstake, T.3
  • 28
    • 2642579895 scopus 로고    scopus 로고
    • CRP as a mediator of disease
    • Yeh ETH,. CRP as a mediator of disease. Circulation 2004; 109: 11-14.
    • (2004) Circulation , vol.109 , pp. 11-14
    • Yeh, E.T.H.1
  • 29
    • 33644682193 scopus 로고    scopus 로고
    • Increased concentration of proatherogenic inflammatory cytokines in systemic lupus erythematosus: Relationship to cardiovascular risk factors
    • Asanuma Y, Chung CP, Oeser A, et al. Increased concentration of proatherogenic inflammatory cytokines in systemic lupus erythematosus: relationship to cardiovascular risk factors. J Rheumatol 2006; 33: 539-545.
    • (2006) J Rheumatol , vol.33 , pp. 539-545
    • Asanuma, Y.1    Chung, C.P.2    Oeser, A.3
  • 30
    • 67349169971 scopus 로고    scopus 로고
    • High frequency of lipoprotein risk levels for cardiovascular disease in Takayasu arteritis
    • de Carvalho JF, Bonfá E, Bezerra MC, Pereira RM,. High frequency of lipoprotein risk levels for cardiovascular disease in Takayasu arteritis. Clin Rheumatol 2009; 28: 801-805.
    • (2009) Clin Rheumatol , vol.28 , pp. 801-805
    • De Carvalho, J.F.1    Bonfá, E.2    Bezerra, M.C.3    Pereira, R.M.4
  • 31
    • 8444224272 scopus 로고    scopus 로고
    • Anti-lipoprotein lipase antibodies: A new player in the complex atherosclerotic process in systemic lupus erythematosus?
    • de Carvalho JF, Borba EF, Viana VS, Bueno C, Leon EP, Bonfá E,. Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus? Arthritis Rheum 2004; 50: 3610-3615.
    • (2004) Arthritis Rheum , vol.50 , pp. 3610-3615
    • De Carvalho, J.F.1    Borba, E.F.2    Viana, V.S.3    Bueno, C.4    Leon, E.P.5    Bonfá, E.6
  • 32
    • 0346333033 scopus 로고    scopus 로고
    • Effect of rheumatoid arthritis or systemic lupus erythematosus on the risk of first-time acute myocardial infarction
    • Fischer LM, Schlienger RG, Matter C, Jick H, Meier CR,. Effect of rheumatoid arthritis or systemic lupus erythematosus on the risk of first-time acute myocardial infarction. Am J Cardiol 2004; 93: 198-200.
    • (2004) Am J Cardiol , vol.93 , pp. 198-200
    • Fischer, L.M.1    Schlienger, R.G.2    Matter, C.3    Jick, H.4    Meier, C.R.5
  • 33
    • 0034761724 scopus 로고    scopus 로고
    • Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus
    • Esdaile JM, Abrahamowicz M, Grodzicky T, et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 2001; 44: 2331-2337.
    • (2001) Arthritis Rheum , vol.44 , pp. 2331-2337
    • Esdaile, J.M.1    Abrahamowicz, M.2    Grodzicky, T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.